A bioinformatics screen identifies TCF19 as an aggressiveness-sustaining gene in prostate cancer.

Mol Oncol · 2025 · PMC12688178 · PMID 40952912

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

p27 and CCND1 mRNA levels showed a nonsignificant trend toward elevation, and only p21 gene expression was significantly elevated in TCF19‐silenced tumors (Fig.

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.